High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease

Published:2018-07 Issue:7 Volume:16 Page:1106-1113.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Shah Shailja C.^ORCID,ten Hove Joren R.,Castaneda Daniel^ORCID,Palmela Carolina^ORCID,Mooiweer Erik,Colombel Jean-Frédéric,Harpaz Noam,Ullman Thomas A.,van Bodegraven Ad A.,Jansen Jeroen M.,Mahmmod Nofel,van der Meulen-de Jong Andrea E.,Ponsioen Cyriel Y.,van der Woude Christine J.,Oldenburg Bas,Itzkowitz Steven H.,Torres Joana

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies;Lutgens;Inflamm Bowel Dis,2013

2. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies;Jess;Clin Gastroenterol Hepatol,2012

3. High lifetime risk of cancer in primary sclerosing cholangitis;Claessen;J Hepatol,2009

4. Advances in primary sclerosing cholangitis;Horsley-Silva;Lancet Gastroenterol Hepatol,2016

5. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease;Torres;Aliment Pharmacol Ther,2011

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional Yield of Random Biopsy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis;Clinical Gastroenterology and Hepatology;2024-07

2. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis;American Journal of Surgical Pathology;2024-05-29

3. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury;Hepatology;2024-05-14

4. Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer;Frontiers in Oncology;2024-01-15

5. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?;Journal of Hepatology;2024-01